Search Results 1491-1500 of 23707 for oral

  1. Drugs and Supplements that Start with D - Mayo Clinic

    Da · Dabigatran (oral route) · Dabrafenib (oral route) · Dacarbazine. Also known as. Dacarbazine (intravenous route, injection route) · Dacarbazine (intravenous ...

  2. Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE) - Mayo Clinic

    This is a continuation study of Budesonide Oral Suspension (BOS) in adults and adolescents with Eosinophilic Esophagitis (EoE) who have completed participation ...

  3. Cavities and tooth decay - Diagnosis and treatment - Mayo Clinic

    Bring in any mouthguards or oral appliances that you wear. Questions to ask your dentist. Basic questions to ask your dentist may include: Do I have a ...

  4. Drugs and Supplements that Start with D - Mayo Clinic

    Da · Dabigatran (oral route) · Dabrafenib (oral route) · Dacarbazine. Also known as. Dacarbazine (intravenous route, injection route) · Dacarbazine (intravenous ...

  5. Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer

    A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) ...

  6. Drugs and Supplements that Start with T - Mayo Clinic

    Tabloid. Also known as. Thioguanine (oral route) · Tabrecta. Also known as. Capmatinib (oral route) · Tachosil. Also known as. Fibrinogen and thrombin, human ( ...

  7. Oral N-acetylcysteine for Retinitis Pigmentosa - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of oral N-acetylcysteine (NAC) in patients with retinitis pigmentosa (RP). Participation ...

  8. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

    The study will evaluate oral daily administration of eFT508. Treatment and study subject evaluation will be performed in 21-day cycles. Participation ...

  9. Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. - Mayo Clinic

    Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. · More about research at Mayo Clinic.

  10. Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome - Mayo Clinic

    This study will determine the safety profile, maximum tolerated dose (MTD), dose-limiting toxicities (DLT), and recommended Phase 2 dose (RP2D) of SX-682 in the ...